ZUTRIPRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zutripro, and when can generic versions of Zutripro launch?
Zutripro is a drug marketed by Persion and is included in one NDA.
The generic ingredient in ZUTRIPRO is chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZUTRIPRO?
- What are the global sales for ZUTRIPRO?
- What is Average Wholesale Price for ZUTRIPRO?
Summary for ZUTRIPRO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 1 |
| Drug Prices: | Drug price information for ZUTRIPRO |
| DailyMed Link: | ZUTRIPRO at DailyMed |
US Patents and Regulatory Information for ZUTRIPRO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Persion | ZUTRIPRO | chlorpheniramine maleate; hydrocodone bitartrate; pseudoephedrine hydrochloride | SOLUTION;ORAL | 022439-001 | Jun 8, 2011 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
